DANIEL REEDER: Open Payments
NPI 1265214662 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 13 payments from 6 companies in 2025. Trend: 2023 $178 · 2024 $583 · 2025 $339
Food & beverage: $304Education: $35
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 4 | $136 |
| Astellas Pharma US Inc | 2 | $54 |
| Teleflex LLC | 2 | $51 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 1 | $35 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
Products named: PROVENGE, GEMTESA, IMFINZI, Xtandi, BARRIGEL, Padcev, UROLIFT, AZMIRO.
Industry payments across TN — which companies pay providers there.
